Work

A Regimen Combining the Wee1 Inhibitor AZD1775 With Histone Deacetylase Inhibitor Vorinostat is Highly Active Against Head and Neck Squamous Cell Carcinoma Harboring High-risk TP53 Mutations

Year: 2016

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2015.12.258

Authors: A.A. Osman, N. Tanaka, N.L. Silver, N.N. Kalu, A.A. Patel, J. Wang, L. Tang, M.J. Frederick, F.M. Johnson, S. Fu, J.N. Myers

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2295850199

FWCI:

Cites:

Cited by:

Related to: 10